These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 1864271)

  • 1. Intracellular distribution and activity of antibiotics.
    Tulkens PM
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):100-6. PubMed ID: 1864271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections.
    Tulkens PM
    Scand J Infect Dis Suppl; 1990; 74():209-17. PubMed ID: 2097709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracellular pharmacokinetics and pharmacodynamics of antibiotics].
    Tulkens PM
    Rev Pneumol Clin; 1996; 52 Suppl 2():S51-5. PubMed ID: 9033918
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.
    Barcia-Macay M; Seral C; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2006 Mar; 50(3):841-51. PubMed ID: 16495241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy and antagonism of combinations with quinolones.
    Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):255-61. PubMed ID: 1864285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotics, developments and orientation].
    de Marie S; Verbrugh HA
    Ned Tijdschr Geneeskd; 1992 Apr; 136(14):673-8. PubMed ID: 1560853
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones.
    Dudley MN
    Am J Med; 1991 Dec; 91(6A):45S-50S. PubMed ID: 1767806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Penetration of antimicrobial agents into phagocytic cells. Does this determine their therapeutic efficiency?].
    Pascual A
    Enferm Infecc Microbiol Clin; 1989; 7(7):345-7. PubMed ID: 2490458
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM; Lee GC; Ellis ME
    Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolides: pharmacokinetics and pharmacodynamics.
    Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S17-23. PubMed ID: 11574190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolides and the immune system.
    McDonald PJ; Pruul H
    Scand J Infect Dis Suppl; 1992; 83():34-40. PubMed ID: 1488627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
    Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of antimicrobial resistance].
    Hori S; Hiramatsu K
    Nihon Rinsho; 1994 Feb; 52(2):327-31. PubMed ID: 8126881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic sensitivity of forty-four strains of group EF4 bacteria: study of minimum inhibitory concentrations using the agar dilution method].
    Lion C; de Monchy P; Weber M; Conroy MC; Mory F; Burdin JC
    Pathol Biol (Paris); 1992 May; 40(5):471-8. PubMed ID: 1495829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages.
    Peyrusson F; Butler D; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5747-60. PubMed ID: 26169402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of clinically important resistance to quinolones and other antibiotic groups.
    Lode H
    J Int Med Res; 1990; 18 Suppl 4():27D-36D. PubMed ID: 2282967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and intracellular activity of AM-1155 in phagocytic cells.
    Yamamoto T; Kusajima H; Hosaka M; Fukuda H; Oomori Y; Shinoda H
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2756-9. PubMed ID: 9124835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance: a class effect?
    Prieto J; Calvo A; Gómez-Lus ML
    J Antimicrob Chemother; 2002 Dec; 50 Suppl S2():7-12. PubMed ID: 12556428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-resistance of clinical isolates of methicillin-resistant Staphylococcus aureus to aminoglycosides and fluoroquinolones.
    Uete T; Matsuo K; Uete G
    Jpn J Antibiot; 1992 Aug; 45(8):943-8. PubMed ID: 1433900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.